UK markets close in 5 hours 7 minutes

AgeX Therapeutics, Inc. (AGE)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.6001+0.0201 (+3.47%)
At close: 03:51PM EDT
0.6100 +0.01 (+1.65%)
After hours: 06:33PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
35
40
1,561
1,548
1,376
Cost of revenue
17
19
158
244
364
Gross profit
18
21
1,403
1,304
1,012
Operating expenses
Research development
1,528
1,456
4,978
5,904
6,630
Selling general and administrative
6,346
6,708
7,403
8,139
5,647
Total operating expenses
7,816
8,060
12,074
13,863
12,257
Operating income or loss
-7,798
-8,039
-10,671
-12,559
-11,245
Interest expense
1,425
1,097
-
-
-
Total other income/expenses net
-73
554
44
294
3,398
Income before tax
-9,296
-8,582
-11,126
-12,236
-7,731
Income tax expense
-
0
-150
148
-
Income from continuing operations
-9,296
-8,582
-10,976
-12,384
-7,731
Net income
-9,293
-8,675
-10,865
-12,154
-7,502
Net income available to common shareholders
-9,293
-8,675
-10,865
-12,154
-7,502
Basic EPS
-
-0.23
-0.29
-0.33
-0.21
Diluted EPS
-
-0.23
-0.29
-0.33
-0.21
Basic average shares
-
37,886
37,669
37,271
34,914
Diluted average shares
-
37,886
37,669
37,271
34,914
EBITDA
-
-7,354
-8,989
-11,608
-10,710